Fitbit (Charge / Sense / Versa) vs RingConn (Gen 2 / Gen 3) in 2026

Fitbit (Charge / Sense / Versa)

Fitbit (the Charge 6 band, plus the Sense 2 and Versa 4 watches; founded 2007 by James Park and Eric Friedman, acquired by Google in a deal that closed January 2021 for about $2.1B) is the budget-tier cleared anchor of the biometric cohort. The Charge 6, at about $160, brings cleared AFib/ECG (via electrodes on the Sense line), optical heart rate, SpO2, skin temperature, a Sleep Score and Sleep Profile, a Daily Readiness Score, and stress management, with an optional Fitbit Premium subscription (~$9.99/month).

It is a Google product line, recorded in the registry as a distinct entity from the Pixel Watch and the Google company, and its health stack shares lineage with the Pixel Watch's Fitbit/Google Health algorithms. The throughline: the strongest cardiologist-validation gradient available at a budget price point, with the AI augmenting genuine biometric sensing.

RingConn (Gen 2 / Gen 3)

RingConn (the Gen 2 at about $279, plus the Gen 2 Air and a Gen 3 arriving late May 2026; from RingConn, Shenzhen) is the subscription-free archetype of the biometric ring sub-cohort: all standard features are free for life, the core positioning against Oura's required membership and Whoop's subscription-only model. Its sensors (PPG, skin temperature, SpO2, accelerometer) drive sleep, heart rate and HRV, and a deep-learning sleep-apnea / AHI screening feature, with 10-to-12-day battery (the charging case extends to about 150 days).

The verified-vs-claimed throughline: the sleep-apnea / AHI feature is a company-claimed screening capability (RingConn cites about 90.7% accuracy) that is NOT FDA-cleared. RingConn's own materials say it is 'actively pursuing clearance' and 'not intended to diagnose'; DEPLOY records the AHI claim as claimed, not cleared, the direct counterpoint to the genuinely-cleared Happy Ring in the same form factor.

On the patent front, RingConn settled and licensed cleanly in the smart-ring ITC litigation; it was not import-banned, unlike Ultrahuman. Price is $279, subscription-free.